Abstract
This study aimed to determine the predictive value of lower extremity deep vein thrombosis (LE-DVT) on first cancer recurrence in patients with stage III colon cancer. A total of 113 eligible patients with stage III colon cancer were divided into two groups according to whether they had LE-DVT. LE-DVT was detected in 29 (26 %) patients. Presence of recurrence with distant metastasis had a significant positive correlation with baseline platelet count, baseline mean platelet volume, and the presence of lower extremity deep vein thrombosis. It was concluded that the relation between disease progression and the presence of LE-DVT in stage III colon cancer is independent of other study variables (P = 0.031; OR = 4.27; 95 % CI 1.89–6.71). We hypothesized that the presence of LE-DVT in patients with stage III colon cancer may predict to early cancer recurrence with distant metastasis.
Similar content being viewed by others
References
Falanga A, Zacharski L. Deep vein thrombosis in cancer: the scale of the problem and approaches to management. Ann Oncol. 2005;16:696–701.
Lee AYY, Levine MN. Venous thromboembolism and cancer: risks and outcomes. Circulation. 2003;107:17–21.
Marras LC, Geerts WH, Perry JR. The risk of venous thromboembolism is increased throughout the course of malignant glioma: an evidence-based review. Cancer. 2000;89:640–6.
Lyman GH. Venous thromboembolism in the patient with cancer. Cancer. 2011;117:1334–49.
Samama MM. An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients: the Sirius study. Arch Intern Med. 2000;160:3415–20.
Lee AY. Cancer and thromboembolic disease: pathogenic mechanisms. Cancer Treat Rev. 2002;28:137–40.
Tanriverdi O. Predictive value of baseline plasma D-dimers for chemotherapy-induced thrombocytopenia in patients with stage III colon cancer: a pilot study. Asian Pas J Cancer Prev. 2013;14:293–7.
Antoniou D, Pavlakou G, Stathopoulos GP, Karydis I, Chondrou E, et al. Predictive value of D-dimer plasma levels in response and progressive disease in patients with lung cancer. Lung Cancer. 2006;53:205–10.
Sekhon SS, Roy V. Thrombocytopenia in adults: a practical approach to evaluation and management. South Med J. 2006;99:491–8.
Kirwan CC, McDowell G, McCollum CN, Kumar S, Byrne GJ. Early changes in the haemostatic and procoagulant systems after chemotherapy for breast cancer. Br J Cancer. 2008;99:1000–6.
Gulcan M, Varol E, Etli M, Aksoy F, Kayan M. Mean platelet volume is increased in patients with deep vein thrombosis. Clin Appl Thromb Hemost. 2012;18:427–30.
Bilir C, Engin H, Bilir F. Increased mean platelet volume in deep vein thrombosis patients with cancer. J Hematol. 2013;2:64–8.
Goldenberg N, Kahn SR, Solymoss S. Markers of coagulation and angiogenesis in cancer-associated venous thromboembolism. J Clin Oncol. 2003;21:4194–9.
Sorensen HT, Mellemkj’r L, Olsen JH, Baron JA. Prognosis of cancers associated with venous thromboembolism. N Engl J Med. 2000;343:1846–50.
Seifter EJ, Young RC, Longo DL. Deep venous thrombosis during therapy for Hodgkin’s disease. Cancer Treat Rep. 1985;69:1011–3.
Acknowledgments
We would like to thank Roche Oncology Department of Medical Support for translating to English.
Conflict of interest
Authors declared no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tanriverdi, O., Yildirim, B., Gul, S. et al. Is there any effect of lower extremity deep vein thrombosis which proven by Doppler ultrasonography on cancer recurrence in patients with stage III colon cancer? A study of the Turkish Descriptive Oncological Researches Group. Med Oncol 31, 215 (2014). https://doi.org/10.1007/s12032-014-0215-1
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s12032-014-0215-1